Sino Biological Acquires SignalChem Biotech

Sino Biological Acquires SignalChem Biotech

By, Admin 1 May 2024

China's Sino Biological acquires Canadian firm SignalChem Biotech for $48 M

Overview

The strategic synergy between Sino Biological and SignalChem enables the provision of a broader range of products and research services China-based Sino Biological, Inc. has concluded the acquisition of Canadian biotechnology company SignalChem Biotech Inc. (SCB). Sino Biological has acquired 100% of SCB shares in a deal valued at $48 million, inclusive of all assets, assumed indebtedness, and net of cash deposits.  

SignalChem Biotech Inc.

  • SignalChem Biotech Inc. is renowned for its specialised bioactive enzymes, including kinases, proteases, phosphatases, ubiquitin and epigenetic enzymes. 
  • Over the past two decades, SCB has established proprietary production and quality control platforms, setting industry standards for the development and production of high-quality bioactive enzyme proteins to support scientists from basic research through drug discovery and development. 
  • Now operating as a wholly-owned subsidiary of Sino Biological, SCB will bring exclusive expertise in enzyme production to the company’s existing technology platforms.

The Synergy

The strategic synergy between Sino Biological and SignalChem enables the provision of a broader range of products and research services, supporting the wider life sciences community and facilitating the discovery and development of novel treatments, vaccines and diagnostic platforms.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!